カテゴリー： QYResearch, 世界

世界の鎌状赤血球症薬市場

◆英語タイトル：Global Sickle Cell Disease Drug Market Professional Survey Report 2019
◆商品コード：DATA909X15027
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：112
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、鎌状赤血球症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他に、用途別には、病院、診療所、その他にセグメント区分し、鎌状赤血球症薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・鎌状赤血球症薬の世界市場概要
・鎌状赤血球症薬の製造コスト構成分析
・鎌状赤血球症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・鎌状赤血球症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・鎌状赤血球症薬のセグメント分析（種類別）
（ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他）
・鎌状赤血球症薬のセグメント分析（用途別）
（病院、診療所、その他）
・鎌状赤血球症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Acceleron Pharma Inc、Addmedica SAS、Angiocrine Bioscience Inc、Annexin Pharmaceuticals AB、ArQule Inc、Bio Products Laboratory Ltd、Bioverativ Inc、bluebird bio Inc、Bristol-Myers Squibb Co、Calimmune Inc、CRISPR Therapeutics、CSL Ltd、Daiichi Sankyo Co Ltd、Editas Medicine Inc、Errant Gene Therapeutics LLC、Gamida Cell Ltd、Genethon SA、Gilead Sciences Inc、Global Blood Therapeutics Inc、）
・鎌状赤血球症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Sickle Cell Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Sickle Cell Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sickle Cell Disease Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Sickle Cell Disease Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Sickle Cell Disease Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Acceleron Pharma Inc
Addmedica SAS
Angiocrine Bioscience Inc
Annexin Pharmaceuticals AB
ArQule Inc
Bio Products Laboratory Ltd
Bioverativ Inc
bluebird bio Inc
Bristol-Myers Squibb Co
Calimmune Inc
CRISPR Therapeutics
CSL Ltd
Daiichi Sankyo Co Ltd
Editas Medicine Inc
Errant Gene Therapeutics LLC
Gamida Cell Ltd
Genethon SA
Gilead Sciences Inc
Global Blood Therapeutics Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
ARQ-092
BIVV-003
CAL-H
CTX-001
DRX-194
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Sickle Cell Disease Drug
1.1 Definition of Sickle Cell Disease Drug
1.2 Sickle Cell Disease Drug Segment by Type
1.2.1 Global Sickle Cell Disease Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 ARQ-092
1.2.3 BIVV-003
1.2.4 CAL-H
1.2.5 CTX-001
1.2.6 DRX-194
1.2.7 Others
1.3 Sickle Cell Disease Drug Segment by Applications
1.3.1 Global Sickle Cell Disease Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Sickle Cell Disease Drug Overall Market
1.4.1 Global Sickle Cell Disease Drug Revenue (2014-2025)
1.4.2 Global Sickle Cell Disease Drug Production (2014-2025)
1.4.3 North America Sickle Cell Disease Drug Status and Prospect (2014-2025)
1.4.4 Europe Sickle Cell Disease Drug Status and Prospect (2014-2025)
1.4.5 China Sickle Cell Disease Drug Status and Prospect (2014-2025)
1.4.6 Japan Sickle Cell Disease Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Sickle Cell Disease Drug Status and Prospect (2014-2025)
1.4.8 India Sickle Cell Disease Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Sickle Cell Disease Drug
2.3 Manufacturing Process Analysis of Sickle Cell Disease Drug
2.4 Industry Chain Structure of Sickle Cell Disease Drug

3 Development and Manufacturing Plants Analysis of Sickle Cell Disease Drug
3.1 Capacity and Commercial Production Date
3.2 Global Sickle Cell Disease Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Sickle Cell Disease Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Sickle Cell Disease Drug Production and Capacity Analysis
4.2 Sickle Cell Disease Drug Revenue Analysis
4.3 Sickle Cell Disease Drug Price Analysis
4.4 Market Concentration Degree

5 Sickle Cell Disease Drug Regional Market Analysis
5.1 Sickle Cell Disease Drug Production by Regions
5.1.1 Global Sickle Cell Disease Drug Production by Regions
5.1.2 Global Sickle Cell Disease Drug Revenue by Regions
5.2 Sickle Cell Disease Drug Consumption by Regions
5.3 North America Sickle Cell Disease Drug Market Analysis
5.3.1 North America Sickle Cell Disease Drug Production
5.3.2 North America Sickle Cell Disease Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Sickle Cell Disease Drug Import and Export
5.4 Europe Sickle Cell Disease Drug Market Analysis
5.4.1 Europe Sickle Cell Disease Drug Production
5.4.2 Europe Sickle Cell Disease Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Sickle Cell Disease Drug Import and Export
5.5 China Sickle Cell Disease Drug Market Analysis
5.5.1 China Sickle Cell Disease Drug Production
5.5.2 China Sickle Cell Disease Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Sickle Cell Disease Drug Import and Export
5.6 Japan Sickle Cell Disease Drug Market Analysis
5.6.1 Japan Sickle Cell Disease Drug Production
5.6.2 Japan Sickle Cell Disease Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Sickle Cell Disease Drug Import and Export
5.7 Southeast Asia Sickle Cell Disease Drug Market Analysis
5.7.1 Southeast Asia Sickle Cell Disease Drug Production
5.7.2 Southeast Asia Sickle Cell Disease Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Sickle Cell Disease Drug Import and Export
5.8 India Sickle Cell Disease Drug Market Analysis
5.8.1 India Sickle Cell Disease Drug Production
5.8.2 India Sickle Cell Disease Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Sickle Cell Disease Drug Import and Export

6 Sickle Cell Disease Drug Segment Market Analysis (by Type)
6.1 Global Sickle Cell Disease Drug Production by Type
6.2 Global Sickle Cell Disease Drug Revenue by Type
6.3 Sickle Cell Disease Drug Price by Type

7 Sickle Cell Disease Drug Segment Market Analysis (by Application)
7.1 Global Sickle Cell Disease Drug Consumption by Application
7.2 Global Sickle Cell Disease Drug Consumption Market Share by Application (2014-2019)

8 Sickle Cell Disease Drug Major Manufacturers Analysis
8.1 Acceleron Pharma Inc
8.1.1 Acceleron Pharma Inc Sickle Cell Disease Drug Production Sites and Area Served
8.1.2 Acceleron Pharma Inc Product Introduction, Application and Specification
8.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Addmedica SAS
8.2.1 Addmedica SAS Sickle Cell Disease Drug Production Sites and Area Served
8.2.2 Addmedica SAS Product Introduction, Application and Specification
8.2.3 Addmedica SAS Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Angiocrine Bioscience Inc
8.3.1 Angiocrine Bioscience Inc Sickle Cell Disease Drug Production Sites and Area Served
8.3.2 Angiocrine Bioscience Inc Product Introduction, Application and Specification
8.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Annexin Pharmaceuticals AB
8.4.1 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production Sites and Area Served
8.4.2 Annexin Pharmaceuticals AB Product Introduction, Application and Specification
8.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 ArQule Inc
8.5.1 ArQule Inc Sickle Cell Disease Drug Production Sites and Area Served
8.5.2 ArQule Inc Product Introduction, Application and Specification
8.5.3 ArQule Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Bio Products Laboratory Ltd
8.6.1 Bio Products Laboratory Ltd Sickle Cell Disease Drug Production Sites and Area Served
8.6.2 Bio Products Laboratory Ltd Product Introduction, Application and Specification
8.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Bioverativ Inc
8.7.1 Bioverativ Inc Sickle Cell Disease Drug Production Sites and Area Served
8.7.2 Bioverativ Inc Product Introduction, Application and Specification
8.7.3 Bioverativ Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 bluebird bio Inc
8.8.1 bluebird bio Inc Sickle Cell Disease Drug Production Sites and Area Served
8.8.2 bluebird bio Inc Product Introduction, Application and Specification
8.8.3 bluebird bio Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Bristol-Myers Squibb Co
8.9.1 Bristol-Myers Squibb Co Sickle Cell Disease Drug Production Sites and Area Served
8.9.2 Bristol-Myers Squibb Co Product Introduction, Application and Specification
8.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Calimmune Inc
8.10.1 Calimmune Inc Sickle Cell Disease Drug Production Sites and Area Served
8.10.2 Calimmune Inc Product Introduction, Application and Specification
8.10.3 Calimmune Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 CRISPR Therapeutics
8.12 CSL Ltd
8.13 Daiichi Sankyo Co Ltd
8.14 Editas Medicine Inc
8.15 Errant Gene Therapeutics LLC
8.16 Gamida Cell Ltd
8.17 Genethon SA
8.18 Gilead Sciences Inc
8.19 Global Blood Therapeutics Inc

9 Development Trend of Analysis of Sickle Cell Disease Drug Market
9.1 Global Sickle Cell Disease Drug Market Trend Analysis
9.1.1 Global Sickle Cell Disease Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Sickle Cell Disease Drug Regional Market Trend
9.2.1 North America Sickle Cell Disease Drug Forecast 2019-2025
9.2.2 Europe Sickle Cell Disease Drug Forecast 2019-2025
9.2.3 China Sickle Cell Disease Drug Forecast 2019-2025
9.2.4 Japan Sickle Cell Disease Drug Forecast 2019-2025
9.2.5 Southeast Asia Sickle Cell Disease Drug Forecast 2019-2025
9.2.6 India Sickle Cell Disease Drug Forecast 2019-2025
9.3 Sickle Cell Disease Drug Market Trend (Product Type)
9.4 Sickle Cell Disease Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Sickle Cell Disease Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Sickle Cell Disease Drug
Table Global Sickle Cell Disease Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Sickle Cell Disease Drug Production Market Share by Types in 2018
Figure ARQ-092 Product Picture
Figure BIVV-003 Product Picture
Figure CAL-H Product Picture
Figure CTX-001 Product Picture
Figure DRX-194 Product Picture
Figure Others Product Picture
Table Global Sickle Cell Disease Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Sickle Cell Disease Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Sickle Cell Disease Drug Revenue (Million USD) (2014-2025)
Figure Global Sickle Cell Disease Drug Production (K Pcs) (2014-2025)
Figure North America Sickle Cell Disease Drug Market Size (Million USD) (2014-2025)
Figure Europe Sickle Cell Disease Drug Market Size (Million USD) (2014-2025)
Figure China Sickle Cell Disease Drug Market Size (Million USD) (2014-2025)
Figure Japan Sickle Cell Disease Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Sickle Cell Disease Drug Market Size (Million USD) (2014-2025)
Figure India Sickle Cell Disease Drug Market Size (Million USD) (2014-2025)
Table Sickle Cell Disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Sickle Cell Disease Drug in 2018
Figure Manufacturing Process Analysis of Sickle Cell Disease Drug
Figure Industry Chain Structure of Sickle Cell Disease Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Sickle Cell Disease Drug Manufacturing Plants Distribution
Table Sickle Cell Disease Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Sickle Cell Disease Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Sickle Cell Disease Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Sickle Cell Disease Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Sickle Cell Disease Drug Production Share by Manufacturers in 2018
Table Sickle Cell Disease Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Sickle Cell Disease Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Sickle Cell Disease Drug Revenue Share by Manufacturers in 2018
Table Sickle Cell Disease Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Sickle Cell Disease Drug Production by Regions 2014-2019 (K Pcs)
Table Global Sickle Cell Disease Drug Production Market Share by Regions 2014-2019
Figure Global Sickle Cell Disease Drug Production Market Share by Regions in 2018
Table Global Sickle Cell Disease Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Sickle Cell Disease Drug Revenue Market Share by Regions 2014-2019
Figure Global Sickle Cell Disease Drug Revenue Market Share by Regions in 2018
Table Global Sickle Cell Disease Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Sickle Cell Disease Drug Consumption Market Share by Regions 2014-2019
Figure North America Sickle Cell Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Sickle Cell Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Sickle Cell Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Sickle Cell Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Sickle Cell Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Sickle Cell Disease Drug Production, Consumption Import and Export (K Pcs)
Figure China Sickle Cell Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Sickle Cell Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Sickle Cell Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Sickle Cell Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Sickle Cell Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Sickle Cell Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Sickle Cell Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Sickle Cell Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Sickle Cell Disease Drug Production, Consumption Import and Export (K Pcs)
Figure India Sickle Cell Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Sickle Cell Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Sickle Cell Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Sickle Cell Disease Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Sickle Cell Disease Drug Market Share by Application (2014-2019)
Table Acceleron Pharma Inc Sickle Cell Disease Drug Production Sites and Area Served
Table Acceleron Pharma Inc Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Acceleron Pharma Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Acceleron Pharma Inc Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Acceleron Pharma Inc Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Acceleron Pharma Inc Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Acceleron Pharma Inc Sickle Cell Disease Drug Main Business and Markets Served
Table Addmedica SAS Sickle Cell Disease Drug Production Sites and Area Served
Table Addmedica SAS Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Addmedica SAS Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Addmedica SAS Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Addmedica SAS Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Addmedica SAS Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Addmedica SAS Sickle Cell Disease Drug Main Business and Markets Served
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Production Sites and Area Served
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Angiocrine Bioscience Inc Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Main Business and Markets Served
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production Sites and Area Served
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Annexin Pharmaceuticals AB Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Main Business and Markets Served
Table ArQule Inc Sickle Cell Disease Drug Production Sites and Area Served
Table ArQule Inc Sickle Cell Disease Drug Product Introduction, Application and Specification
Table ArQule Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ArQule Inc Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table ArQule Inc Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure ArQule Inc Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table ArQule Inc Sickle Cell Disease Drug Main Business and Markets Served
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Production Sites and Area Served
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Bio Products Laboratory Ltd Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Main Business and Markets Served
Table Bioverativ Inc Sickle Cell Disease Drug Production Sites and Area Served
Table Bioverativ Inc Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Bioverativ Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bioverativ Inc Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Bioverativ Inc Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Bioverativ Inc Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Bioverativ Inc Sickle Cell Disease Drug Main Business and Markets Served
Table bluebird bio Inc Sickle Cell Disease Drug Production Sites and Area Served
Table bluebird bio Inc Sickle Cell Disease Drug Product Introduction, Application and Specification
Table bluebird bio Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table bluebird bio Inc Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table bluebird bio Inc Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure bluebird bio Inc Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table bluebird bio Inc Sickle Cell Disease Drug Main Business and Markets Served
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Production Sites and Area Served
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Co Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Main Business and Markets Served
Table Calimmune Inc Sickle Cell Disease Drug Production Sites and Area Served
Table Calimmune Inc Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Calimmune Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Calimmune Inc Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Calimmune Inc Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Calimmune Inc Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Calimmune Inc Sickle Cell Disease Drug Main Business and Markets Served
Table CRISPR Therapeutics Sickle Cell Disease Drug Production Sites and Area Served
Table CSL Ltd Sickle Cell Disease Drug Production Sites and Area Served
Table Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Production Sites and Area Served
Table Editas Medicine Inc Sickle Cell Disease Drug Production Sites and Area Served
Table Errant Gene Therapeutics LLC Sickle Cell Disease Drug Production Sites and Area Served
Table Gamida Cell Ltd Sickle Cell Disease Drug Production Sites and Area Served
Table Genethon SA Sickle Cell Disease Drug Production Sites and Area Served
Table Gilead Sciences Inc Sickle Cell Disease Drug Production Sites and Area Served
Table Global Blood Therapeutics Inc Sickle Cell Disease Drug Production Sites and Area Served
Figure Global Sickle Cell Disease Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Sickle Cell Disease Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Sickle Cell Disease Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Sickle Cell Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Sickle Cell Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Sickle Cell Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Sickle Cell Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Sickle Cell Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Sickle Cell Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Sickle Cell Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Sickle Cell Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Sickle Cell Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Sickle Cell Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Sickle Cell Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Sickle Cell Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Sickle Cell Disease Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Sickle Cell Disease Drug by Application (2019-2025)
Table Sickle Cell Disease Drug Distributors List
Table Sickle Cell Disease Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Acceleron Pharma Inc、Addmedica SAS、Angiocrine Bioscience Inc、Annexin Pharmaceuticals AB、ArQule Inc、Bio Products Laboratory Ltd、Bioverativ Inc、bluebird bio Inc、Bristol-Myers Squibb Co、Calimmune Inc、CRISPR Therapeutics、CSL Ltd、Daiichi Sankyo Co Ltd、Editas Medicine Inc、Errant Gene Therapeutics LLC、Gamida Cell Ltd、Genethon SA、Gilead Sciences Inc、Global Blood Therapeutics Inc、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の鎌状赤血球症薬市場(Global Sickle Cell Disease Drug Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp